Teva Pharmaceutical Industries - 29 Year Stock Price History | TEVA

Historical daily share price chart and data for Teva Pharmaceutical Industries since 1990 adjusted for splits. The latest closing stock price for Teva Pharmaceutical Industries as of April 25, 2019 is 15.14.
  • The all-time high Teva Pharmaceutical Industries stock price is 67.06, which is 342.9% above the current share price.
  • The Teva Pharmaceutical Industries 52-week high stock price is 25.65, which is 69.4% above the current share price.
  • The Teva Pharmaceutical Industries 52-week low stock price is 14.22, which is 6.1% below the current share price.
  • The average Teva Pharmaceutical Industries stock price for the last 52 weeks is 20.28.
Teva Pharmaceutical Industries Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 16.9934 15.8500 20.0100 14.2200 15.1400 -1.82%
2018 20.9176 19.1100 25.6500 14.5900 15.4200 -18.63%
2017 25.1752 36.2877 36.7524 11.1652 18.9500 -46.01%
2016 48.5120 61.4736 62.0008 33.9156 35.0968 -43.20%
2015 57.4253 51.7518 67.0558 50.5644 61.7937 16.73%
2014 46.9148 36.1043 53.7549 35.7635 52.9393 47.29%
2013 34.4799 32.4379 37.1235 32.4379 35.9429 10.36%
2012 35.9346 36.8548 39.4116 32.2286 32.5688 -5.63%
2011 38.5499 44.2345 47.3106 30.0250 34.5118 -21.23%
2010 46.0024 48.0507 53.7257 39.3724 43.8142 -6.06%
2009 39.9240 35.0590 46.7142 34.0725 46.6394 33.28%
2008 36.8902 38.2007 40.4406 30.9902 34.9932 -7.37%
2007 32.8761 25.2087 38.0625 25.2087 37.7780 50.73%
2006 29.2785 35.2174 35.2174 23.8544 25.0635 -27.08%
2005 26.6383 23.1818 36.3841 21.3405 34.3703 45.04%
2004 23.6841 22.8660 27.1200 18.7397 23.6976 5.76%
2003 20.0211 15.4815 24.2331 13.6685 22.4076 47.25%
2002 12.7675 12.1533 15.5918 10.2099 15.2174 25.60%
2001 11.9083 12.9320 14.3495 9.9910 12.1159 -15.74%
2000 10.4833 6.8561 15.3062 6.2984 14.3787 104.78%
1999 4.7438 4.1278 7.0216 3.8962 7.0216 76.63%
1998 3.9448 4.7305 4.8708 3.1335 3.9754 -13.74%
1997 5.3845 4.8025 6.5470 4.1343 4.6087 -5.58%
1996 4.0556 4.4656 4.8939 2.9571 4.8812 8.70%
1995 3.4050 2.3136 4.5624 2.0783 4.4907 92.58%
1994 2.6080 2.9030 3.2868 2.1614 2.3319 -19.33%
1993 2.3858 2.2125 3.2127 1.7820 2.8905 37.70%
1992 1.3099 1.0536 2.1407 0.9589 2.0991 134.77%
1991 0.7238 0.5536 0.9342 0.5183 0.8941 65.02%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $15.253B $18.854B
TEVA Pharmaceuticals USA, the business is to develop, manufacture, and market generic pharmaceuticals. Teva USA sells its products to chains, wholesalers, distributors, hospitals, managed care entities, and government agencies. The company markets a variety of dosage forms, including both extended and immediate release tablets and capsules, creams, ointments, solutions, and suspensions. Key therapeutic areas are the analgesic, anti-infective, cardiovascular, CNS, dermatological and anti-inflammatory categories.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $46.453B 8.36
Mylan (MYL) United Kingdom $13.642B 5.77
Bausch Health Cos (BHC) Canada $8.049B 5.72
Dr Reddy's Laboratories (RDY) India $6.783B 27.05
Supernus Pharmaceuticals (SUPN) United States $1.934B 17.94
Mallinckrodt Public Limited Company (MNK) United Kingdom $1.520B 2.47
Amphastar Pharmaceuticals (AMPH) United States $0.979B 90.48
Homology Medicines (FIXX) United States $0.829B 0.00
Voyager Therapeutics (VYGR) United States $0.774B 0.00
CymaBay Therapeutics (CBAY) United States $0.756B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.417B 0.00
Assembly Biosciences (ASMB) United States $0.399B 0.00
Akorn (AKRX) United States $0.365B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.211B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.173B 0.00
Sol-Gel Technologies (SLGL) Israel $0.132B 0.00
Acasti Pharma (ACST) Canada $0.070B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.064B 0.00
Agile Therapeutics (AGRX) United States $0.064B 0.00
Teligent (TLGT) United States $0.054B 0.00
China Pharma Holdings (CPHI) China $0.016B 0.00
Aevi Genomic Medicine (GNMX) United States $0.014B 0.00
Evoke Pharma (EVOK) United States $0.012B 0.00